Alembic Pharmaceuticals has informed the exchange that the Company has successfully completed the United States Food and Drug Administration (USFDA) inspection for its Derma Facility located at Karakhadi without any observations. The inspection was conducted from 6th March, 2023 to 10th March, 2023.
The above information is a part of company’s filings submitted to BSE.